Medinol Obtains CE Mark for Presillion Stent
Posted on: Tuesday, 13 May 2008, 09:00 CDT
Medinol has received CE Mark for its Presillion CoCr Coronary Stent, to treat coronary artery lesions with a technologically innovative flexible closed cell design stent.
The Presillion comes in diameters ranging from 2.5-4mm and in lengths ranging from 8-32mm. The Presillion stent system can be used to treat various lesion types: de novo, restenotic lesions, total occlusions, bifurcations, and acute myocardial infarction. Medinol partnered with Cordis, a Johnson and Johnson company, for distribution of Presillion globally.
Kobi Richter, chairman of the board and chief technology officer of Medinol, said: "Cobalt Chromium enables us to reduce the strut thickness and overall cell size by up to 25% compared to stainless steel while retaining superior scaffolding through the unique flexible closed cell design; this material also maintains a much higher fatigue resistance and radiopacity than the common stainless steel stents."
Source: Datamonitor
User Comments (0)
RSS Feeds